Ultragenyx Pharmaceutical Inc.
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.
On November 10, 2022, Ultragenyx Pharmaceutical Inc. (the “ Company ”) announced that Mardi Dier had informed the Company of her decision to voluntarily resign from her position as the Company’s Executive Vice President and Chief Financial Officer, effective as of November 15, 2022, to pursue another opportunity.
Extracted from this filing and checked against the source text.
Mardi Dier resigned as Executive Vice President and Chief Financial Officer at Ultragenyx Pharmaceutical Inc..
On November 10, 2022, Ultragenyx Pharmaceutical Inc. (the “ Company ”) announced that Mardi Dier had informed the Company of her decision to voluntarily resign from her position as the Company’s Executive Vice President and Chief Financial Officer, effective as of November 15, 2022, to pursue another opportunity.View on SEC.gov
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.